Molecular basis for deficient acetaminophen glucuronidation in cats
- 1 April 1997
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (7) , 1041-1047
- https://doi.org/10.1016/s0006-2952(97)00072-5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (MH-34223, MH-I9924)
- National Center for Research Resources
This publication has 25 references indexed in Scilit:
- Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N‐demethylationBritish Journal of Clinical Pharmacology, 1996
- Inhibition of acetaminophen and lorazepam glucuronidationin vitro by probenecidBiopharmaceutics & Drug Disposition, 1993
- Alprazolam Metabolism in vitro: Studies of Human, Monkey, Mouse, and Rat Liver MicrosomesPharmacology, 1993
- Molecular Aspects of Paracetamol-Induced Hepatotoxicity and its Mechanism-Based PreventionDrug Metabolism Reviews, 1992
- The toxicity and biotransformation of single doses of acetaminophen in dogs and catsToxicology and Applied Pharmacology, 1984
- Paracetamol Overdosage Pharmacological Considerations and Clinical ManagementDrugs, 1983
- Hepatic phase I and phase II biotransformations in quail and trout: Comparison to other species commonly used in toxicity testingToxicology and Applied Pharmacology, 1983
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- The Conjugation of 1- and 2-Naphthols and other Phenols in the Cat and PigXenobiotica, 1974
- The Fate of [14C]Phenol in Various SpeciesXenobiotica, 1972